Title:
ANTI-HUMAN B CELL MATURATION ANTIGEN (BCMA) ANTIBODIES AND THEIR USE IN IMMUNOHISTOCHEMISTRY (IHC)
Document Type and Number:
WIPO Patent Application WO/2023/167903
Kind Code:
A3
Abstract:
In alternative embodiments, provided are chimeric or recombinant anti-human B-cell maturation antigen (BCMA, or BCM) polypeptide (also called tumor necrosis factor receptor superfamily member 17 (TNFRSF17)) antibodies, including products of manufacture and kits comprising them, and methods for making and using them, including for example their use in the detection or diagnosis of a cancer or other conditions. In alternative embodiments, anti-BCMA antibodies as provided herein are used together with an agent for determining whether BCMA expression or activity is reduced or absent.
Inventors:
SØRENSEN MORTEN DRAEBY (US)
HAGEDORN-OLSEN TINE (US)
HOFF KIRSTEN (US)
HAGEDORN-OLSEN TINE (US)
HOFF KIRSTEN (US)
Application Number:
PCT/US2023/014239
Publication Date:
November 16, 2023
Filing Date:
March 01, 2023
Export Citation:
Assignee:
AGILENT TECHNOLOGIES INC (US)
International Classes:
C07K16/28; A61K39/00; G01N33/532; G01N33/574
Foreign References:
| US20210332145A1 | 2021-10-28 | |||
| US20200362048A1 | 2020-11-19 | |||
| US20200392236A1 | 2020-12-17 | |||
| US20190382500A1 | 2019-12-19 | |||
| US20170283504A1 | 2017-10-05 |
Attorney, Agent or Firm:
EINHORN, Gregory P. (US)
Download PDF:
Previous Patent: ENGAGEMENT ANALYSIS FOR REMOTE COMMUNICATION SESSIONS
Next Patent: HIGH MODULUS GEL-SPUN PVDF FIBER THIN FILMS
Next Patent: HIGH MODULUS GEL-SPUN PVDF FIBER THIN FILMS